Form 8-K - Current report:
SEC Accession No. 0001558370-25-002595
Filing Date
2025-03-10
Accepted
2025-03-10 16:31:24
Documents
16
Period of Report
2025-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20250310x8k.htm   iXBRL 8-K 39906
2 EX-99.1 chrs-20250310xex99d1.htm EX-99.1 435283
3 GRAPHIC chrs-20250310xex99d1001.jpg GRAPHIC 6713
  Complete submission text file 0001558370-25-002595.txt   642018

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20250310.xsd EX-101.SCH 4265
5 EX-101.DEF chrs-20250310_def.xml EX-101.DEF 3158
6 EX-101.LAB chrs-20250310_lab.xml EX-101.LAB 15907
7 EX-101.PRE chrs-20250310_pre.xml EX-101.PRE 10735
18 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250310x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 25724221
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)